Spyre Therapeutics (SYRE) EBIT Margin Growth (1y) (2016 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3,724.00 |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1.96 Mn |
| Mar 31, 2023 | -770,349.00 |
| Dec 31, 2022 | -1.08 Mn |
| Sep 30, 2022 | -1.06 Mn |
| Jun 30, 2022 | -353,180.00 |
| Jun 30, 2018 | 4,772.00 |
| Mar 31, 2018 | 9,868.00 |
| Dec 31, 2017 | -236.00 |
| Sep 30, 2017 | -8,587.00 |
| Jun 30, 2017 | -5,414.00 |
| Mar 31, 2017 | -11,304.00 |
| Dec 31, 2016 | -19,233.00 |
| Sep 30, 2016 | -22,994.00 |
| Jun 30, 2016 | -35,843.00 |